Showing results (61-70 of 351) with videos related to
Sort By:
Pageof 36
Journal of Gastroenterology|September 1, 2004
Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatmentSatoshi Mamori, Fumitaka Suzuki, Tetsuya Hosaka, et al.Journal of Gastroenterology|December 8, 2004
Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis CYasuji Arase, Kenji Ikeda, Fumitaka Suzuki, et al.Internal Medicine (Tokyo, Japan)|March 4, 2008
The efficacy of short-term interferon-beta therapy for chronic hepatitis C patients with low virus loadYusuke Kawamura, Yasuji Arase, Kenji Ikeda, et al.Journal of Medical Virology|February 17, 2006
Natural history of compensated cirrhosis in the Child-Pugh class A compared between 490 patients with hepatitis C and 167 with B virus infectionsMasahiro Kobayashi, Kenji Ikeda, Tetsuya Hosaka, et al.Journal of Gastroenterology|December 25, 2008
Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma: differences between young and elderly patientsHiromi Saneto, Masahiro Kobayashi, Yusuke Kawamura, et al.Hepatology (Baltimore, Md.)|July 28, 2007
Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesisNorio Akuta, Fumitaka Suzuki, Yusuke Kawamura, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 12, 2009
Effectiveness of combination therapy of splenectomy and long-term interferon in patients with hepatitis C virus-related cirrhosis and thrombocytopeniaDaisuke Morihara, Masahiro Kobayashi, Kenji Ikeda, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 2, 2016
Usefulness and limitations of balloon-occluded transcatheter arterial chemoembolization using miriplatin for patients with four or fewer hepatocellular carcinoma nodulesYusuke Kawamura, Kenji Ikeda, Shunichiro Fujiyama, et al.Journal of Medical Virology|June 4, 2016
Favorable efficacy of daclatasvir plus asunaprevir in treatment of elderly Japanese patients infected with HCV genotype 1b aged 70 and olderNorio Akuta, Hitomi Sezaki, Fumitaka Suzuki, et al.Journal of Medical Virology|August 21, 2015
Relationships between serum asunaprevir concentration and alanine aminotransferase elevation during daclatasvir plus asunaprevir for chronic HCV genotype 1b infectionNorio Akuta, Hitomi Sezaki, Fumitaka Suzuki, et al.Pageof 36